ACP Diabetes Monthly
Welcome to this month's issue of ACP Diabetes Monthly, an update for internists published by the American College of Physicians.
In the News for the month of February 2016
Diabetes risk with statins appears to be outweighed by reduction in overall mortality
An observational cohort study examined the effect of statins on diabetes risk and overall mortality in 13,508 normoglycemic patients and 4,563 patients with impaired fasting glucose. More...
Combined canagliflozin, metformin may offer better glycemic control than monotherapy, study finds
The industry-funded, double-blind, randomized, controlled trial assigned adult patients with type 2 diabetes who were not taking antihyperglycemic agents before the study to 26 weeks of treatment in 1 of 5 arms. More...
New risk score for CVD may be easier to use than existing scores in patients with diabetes
Researchers used data from the ADVANCE-ON study to develop the AD-ON risk score, a 10-year risk score for the combined endpoint of major cardiovascular disease (CVD) or chronic kidney disease. More...
MKSAP quiz: Fasting hyperglycemia in type 1 diabetes
This month's quiz asks readers to evaluate a 48-year-old woman with type 1 diabetes who experiences occasional episodes of hyperglycemia in the morning before breakfast. More...
From ACP Journal Club
In patients with type 2 diabetes and CV disease, empagliflozin reduced a composite of CV events at 3.1 years
An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on placebo. A commentary in ACP Journal Club called the trial results fascinating but said they are not yet sufficient to change practice. More...
FDA approves new treatment for diabetic foot ulcers
The approval is an expanded indication for the device, which covers the ulcer and allows skin and tissue to regenerate and heal the wound. More...
Spotlight on guidelines
The American Association of Clinical Endocrinologists and the American College of Endocrinology updated their algorithm for treatment of type 2 diabetes, while the American Diabetes Association released a position statement on management of diabetes in long-term care and skilled nursing facilities. More...
Physician editor: David V. O'Dell, MD, FACP
Has Your Contact Information Changed?
To change your e-mail address or other contact information in our records, go here or call 800-523-1546, ext. 2600 (M-F, 9 a.m. - 5 p.m. ET).
About ACP Diabetes Monthly
ACP Diabetes Monthly is a monthly newsletter produced by the staff of ACP Internist. It is automatically sent to all College members who have an e-mail address on file with ACP.
To add your e-mail address to your member record and to begin receiving ACP Diabetes Monthly, please click here.
Copyright © by American College of Physicians.
A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
Not an ACP Member?
Join today and discover the benefits waiting for you.
ACP offers different categories of membership depending on your career stage and professional status. View options, pricing and benefits.
A New Way to Ace the Boards!
Ensure you're board-exam ready with ACP's Board Prep Ace - a multifaceted, self-study program that prepares you to pass the ABIM Certification Exam in internal medicine. Learn more.